Cargando…

An overview of opportunistic fungal infections associated with COVID-19

The COVID-19 survivors and long-term steroid administered patients exhibit a variety of fungal co-infections. The lives of COVID-19 patients and survivors are hampered by fungal species of the genera Candida, Aspergillus, and Mucor. There have been cases of mucormycosis, aspergillosis, and candidias...

Descripción completa

Detalles Bibliográficos
Autores principales: Kangabam, Navidita, Nethravathy, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257773/
https://www.ncbi.nlm.nih.gov/pubmed/37309405
http://dx.doi.org/10.1007/s13205-023-03648-2
_version_ 1785057362482036736
author Kangabam, Navidita
Nethravathy, V.
author_facet Kangabam, Navidita
Nethravathy, V.
author_sort Kangabam, Navidita
collection PubMed
description The COVID-19 survivors and long-term steroid administered patients exhibit a variety of fungal co-infections. The lives of COVID-19 patients and survivors are hampered by fungal species of the genera Candida, Aspergillus, and Mucor. There have been cases of mucormycosis, aspergillosis, and candidiasis in COVID-19 patients. The treatments given to these opportunistic fungal infections include polyene like amphotericin B, azoles including imidazoles like ketoconazole, miconazole, and triazoles like fluconazole, voriconazole, itraconazole, Echinocandin derivatives like- caspofungin, micafungin, immunomodulatory therapy, granulocyte transfusion, etc. A successful recovery and the reduction of fatalities depend on prompt diagnosis and treatment. To reduce mortality, advanced techniques to identify such uncommon infections at a very early stage are necessary. This review's goal is to provide a summary of the systemic and superficial opportunistic fungal infections that the COVID-19 survivors were dealing with, including information on illness incidence, pathogenicity, and treatment.
format Online
Article
Text
id pubmed-10257773
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-102577732023-06-12 An overview of opportunistic fungal infections associated with COVID-19 Kangabam, Navidita Nethravathy, V. 3 Biotech Review Article The COVID-19 survivors and long-term steroid administered patients exhibit a variety of fungal co-infections. The lives of COVID-19 patients and survivors are hampered by fungal species of the genera Candida, Aspergillus, and Mucor. There have been cases of mucormycosis, aspergillosis, and candidiasis in COVID-19 patients. The treatments given to these opportunistic fungal infections include polyene like amphotericin B, azoles including imidazoles like ketoconazole, miconazole, and triazoles like fluconazole, voriconazole, itraconazole, Echinocandin derivatives like- caspofungin, micafungin, immunomodulatory therapy, granulocyte transfusion, etc. A successful recovery and the reduction of fatalities depend on prompt diagnosis and treatment. To reduce mortality, advanced techniques to identify such uncommon infections at a very early stage are necessary. This review's goal is to provide a summary of the systemic and superficial opportunistic fungal infections that the COVID-19 survivors were dealing with, including information on illness incidence, pathogenicity, and treatment. Springer International Publishing 2023-06-11 2023-07 /pmc/articles/PMC10257773/ /pubmed/37309405 http://dx.doi.org/10.1007/s13205-023-03648-2 Text en © King Abdulaziz City for Science and Technology 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
spellingShingle Review Article
Kangabam, Navidita
Nethravathy, V.
An overview of opportunistic fungal infections associated with COVID-19
title An overview of opportunistic fungal infections associated with COVID-19
title_full An overview of opportunistic fungal infections associated with COVID-19
title_fullStr An overview of opportunistic fungal infections associated with COVID-19
title_full_unstemmed An overview of opportunistic fungal infections associated with COVID-19
title_short An overview of opportunistic fungal infections associated with COVID-19
title_sort overview of opportunistic fungal infections associated with covid-19
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257773/
https://www.ncbi.nlm.nih.gov/pubmed/37309405
http://dx.doi.org/10.1007/s13205-023-03648-2
work_keys_str_mv AT kangabamnavidita anoverviewofopportunisticfungalinfectionsassociatedwithcovid19
AT nethravathyv anoverviewofopportunisticfungalinfectionsassociatedwithcovid19
AT kangabamnavidita overviewofopportunisticfungalinfectionsassociatedwithcovid19
AT nethravathyv overviewofopportunisticfungalinfectionsassociatedwithcovid19